NRC Health (NRC)
NASDAQ: NRC · Real-Time Price · USD
22.00
-0.02 (-0.09%)
Aug 26, 2026, 4:00 PM EDT - Market closed
NRC Health Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 140 | 137.39 | 143.06 | 148.58 | 151.57 | 147.95 |
Revenue Growth | -0.23% | -3.96% | -3.72% | -1.97% | 2.44% | 11.01% |
Gross Profit Gross Profit Growth | 86.45 | 85.02 | 86.13 | 92.57 | 94.52 | 95.6 |
Operating Income Operating Income Growth | 18.05 | 29.38 | 35.45 | 40.09 | 46.56 | 50.74 |
Net Income Net Income Growth | 5.48 | 11.29 | 24.78 | 30.96 | 31.78 | 37.45 |
Earnings Per Share EPS Growth | 0.24 | 0.50 | 1.04 | 1.25 | 1.27 | 1.46 |
EPS Growth | -68.78% | -51.92% | -16.80% | -1.57% | -13.01% | 0.69% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 3.33 | 4.14 | 4.23 | 6.65 | 25.03 | 54.36 |
Total Debt Total Debt Growth | 90.45 | 80.24 | 64.41 | 38.96 | 23.39 | 28.68 |
Net Cash (Debt) Net Cash Growth | -87.12 | -76.1 | -60.18 | -32.3 | 1.64 | 25.68 |
Net Cash Growth | - | - | - | - | -93.61% | 1666.37% |
Net Cash Per Share Net Cash Per Share Growth | -3.97 | -3.40 | -2.53 | -1.31 | 0.07 | 1.00 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 29.51 | 26.45 | 34.63 | 38.11 | 36.27 | 46.34 |
Capital Expenditures CapEx Growth | -7.87 | -10.71 | -15.45 | -15.78 | -9.84 | -5.51 |
Free Cash Flow Free Cash Flow Growth | 21.64 | 15.74 | 19.18 | 22.33 | 26.43 | 40.83 |
Free Cash Flow Growth | 133.40% | -17.90% | -14.13% | -15.50% | -35.27% | 11.40% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 61.75% | 61.88% | 60.20% | 62.30% | 62.36% | 64.62% |
Operating Margin | 12.89% | 21.38% | 24.78% | 26.98% | 30.72% | 34.30% |
Pretax Margin | 6.70% | 12.99% | 22.85% | 26.90% | 28.25% | 32.86% |
Profit Margin | 3.92% | 8.22% | 17.32% | 20.84% | 20.97% | 25.31% |
FCF Margin | 15.46% | 11.46% | 13.41% | 15.03% | 17.44% | 27.60% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.640 | 0.520 | 0.480 | 0.480 | 0.840 | 0.480 |
Dividend Per Share Growth | 33.33% | 8.33% | 0% | -42.86% | 75.00% | 128.57% |
Dividend Yield | 2.91% | 2.82% | 2.86% | 1.30% | 2.50% | 1.31% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 91.52 | 37.66 | 16.71 | 31.36 | 28.96 | 28.20 |
Forward PE | 23.16 | 34.39 | 34.39 | 34.39 | 34.39 | 34.39 |
P/FCF Ratio | 22.49 | 27.01 | 21.59 | 43.48 | 34.83 | 25.87 |
PS Ratio | 3.48 | 3.10 | 2.90 | 6.54 | 6.07 | 7.14 |